Nutrient supplementation modulates angiotensin II-mediated atherosclerosis in ApoE KO mice

Molecular Medicine Reports

Volumn 3, Issue 3, 2010, Pages 417-425

  Ivanov, Vadim ^a   Cha, John ^a   Ivanova, Svetlana ^a   Kalinovsky, Tatiana ^a   Rath, Matthias ^a   Niedzwiecki, Aleksandra ^a  

^a Dr Rath Research Institute   (United States)

Author keywords

Angiotensin II; Aortic dissection; ApoE KO mice; Atherosclerosis

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; ASCORBIC ACID; ASIATIC ACID; CHOLESTEROL; CHOLINE BITARTRATE; COLLAGEN; CYANOCOBALAMIN; CYSTEINE; FOLIC ACID; GLYCINATE COPPER; GOTU KOLA EXTRACT; GREEN TEA EXTRACT; HERBACEOUS AGENT; LOW DENSITY LIPOPROTEIN; LYSINE; METHIONINE; PLANT EXTRACT; PROLINE; PYRIDOXINE; QUERCETIN; UNCLASSIFIED DRUG;

ABDOMINAL AORTA; ABDOMINAL AORTA ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA DISSECTION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CELL DENSITY; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIET; DISEASE SEVERITY; DRUG EFFECT; FEEDING; KNOCKOUT MOUSE; MACROPHAGE; MALE; MONOCYTE; MORBIDITY; MOUSE; NONHUMAN; NUTRIENT; RISK FACTOR; SUPPLEMENTATION; THORACIC AORTA;

MUS;

EID: 77952333405     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000274     Document Type: Article

References (34)

1. lithell h: Pathogenesis and prevalence of atherosclerosis in hypertensive patients. am J hypertens 7: 28-68, 1994.
2. Alexander RW: hypertension and pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammatory response. hypertension 25: 155-161, 1995.
3. Zadelaar S, Kleeman r, Verschuren l, de Vries-van der Weji J, van der hoorn J, Princen HM and Kooistra T: Mouse models for atherosclerosis and pharmaceutical modifiers. Artheroscler Thromb Vasc Biol 27: 1706-1721, 2007.
4. Whitman SC: a practical approach using mice in atherosclerosis research. clin Biochem rev 25: 81-93, 2004.
5. ayabe n, Babaev VR, Tang y, Tanizawa T, Fogo AB, linton MF, ichikawa y, Fazio S and Kon V: Transiently heightened angiotensin ii has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice. atherosclerosis 184: 312-321, 2006.
6. reddick RL, Zhang SH and Maeda N: atherosclerosis in mice lacking apoE. evaluation of lesional development and progression. atheroscler Thromb 14: 141-147, 1994.
7. Ness AR and Powles JW: Fruit and vegetables and cardiovascular disease: a review. int J epidemiol 26: 1-13, 1997.
8. chopra M, O'Neill ME, Keogh n, Wortley G, Southon S and Thurnham DI: Influence of increased fruit and vegetable intake on plasma and lipoprotein caroteniods and LDL oxidation in smokers and nonsmokers. clin chem 46: 1818-1829, 2000.
9. esposito K, nappo F, Giugliano F, Giugliano G, Marfella r and Giugliano d: effect of dietary antioxidants on postprandial endothelial dysfunction induced by a high-fat meal in healthy subjects. am J clin nutr 77: 139-143, 2003.
10. Dragsted LO, Krath B, ravn-Haren G, Vogel UB, Vinggaard AM, Jensen PB, loft S, Rasmussen SE, Sandstrom B and Pedersen a: Biological effects of fruit and vegetables. Proc nutr Soc 65: 61-67, 2006.
11. Silaste ML, rantala M, alfthan G, aro a and Kesaniemi YA: Plasma homocysteine concentration is decreased by dietary intervention. Br J nutr 89: 295-301, 2003.
12. Kneckt P, Jarvinen r, reunanen a and Maaatela J: Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ 312: 478-481, 1996.
13. riemersma RA, Wood DA, Macintyre CCA, elton RA, Gey KF and oliver MF: risk of angina pectoris and plasma concentrations of vitamin A, C and E and carotene. lancet 337: 1-5, 1991.
14. hodis HN, Mack WJ, la Bree l, Selzer rh, liu CR and azen SP: Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 275: 1893-1896, 1996.
15. rath M and niedzwiecki a: nutritional supplement halts progression of early coronary atherosclerosis. J appl nutr 48: 67-78, 1996.
16. Miura y, chiba T, Tomia i, Koizumi h, Miura S, umegaki K, hara y, ikeda M and Tomita T: Tea catechins prevent the development of atherosclerois in apoprotein E-deficient mice. J Nutr 131: 27-32, 2001.
17. Kanters e, Pasparakis M, Gijbels, Vergouwe MN, Partouns-Hendricks i, Fijneman RJ, clausen BE, Förster i, Kockx MM, rajewsky K, Kraal G, hofker MH and de Winther MP: inhibition of NF-κB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J Clin invest 112: 1176-1185, 2003.
18. Vislisela JM, Schafera FQ and Buettner GR: a simple and sensitive assay for ascorbate using a plate reader. anal Biochem 365: 31-39, 2007.
19. ching S, Mahan DC, Moreau RR and dabrowski K: Modification of analytical procedures for determining vitamin C enzyme (L-gulonolactone oxidase) activity in swine liver. J nutr Biochem 14: 139-146, 2003.
20. daugherty a and cassis LA: Mechanisms of abdominal aortic aneurysm formation. curr atheroscler rep 4: 222-227, 2002.
21. Saraff K, Babamusta F, cassis la and daugherty a: aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. arterioscler Thromb Vasc Biol 23: 1621-1626, 2003. (Pubitemid 37108207)
22. Nakamura M, Lee DP and Young AC: Identification and treatment of vulnerable plaque. rev cardiovasc Med 5 (Suppl 2): 22-33, 2004.
23. Peter l and Massanor a: Stabilization of atherosclerotic plaques. new mechanisms and clinical targets. nature Med 8: 1257-1262, 2002.
24. naghavi M, libby P, Falk e, et al: From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part i. circulation 108: 1664-1672, 2003.
25. Witzum JL and Steinberg d: role of oxidized low density lipoprotein in atherogenesis. J clin invest 88: 1785-1792, 1991.
26. heinecke JW: oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. atherosclerosis 141: 1-15, 1998.
27. Marc F, Mark S, Martin G and Michael h: Matrix metalloproteinases in cerebrovascular diseases. cerbrovasc dis 20: 141-151, 2005.
28. Katsuda S, okada y, Minamoto T, oda y, Matsui y and nakanishi i: collagens in human atherosclerosis. Immunohistochemical analysis using collagen type specific antibodies. arterioscler Thromb Vasc Biol 12: 494-502, 1992.
29. ivanov V, ivanova S, roomi MW, Kalinovsky T, niedzwiecki a and rath M: extracellular matrix-mediated control aortic smooth muscle cell growth and migration by a combination of ascorbic acid, lysine, proline, and catechins. J cardiovasc Pharmacol 50: 541-547, 2007.
30. ivanov V, roomi MW, Kalinovsky T, niedzwiecki a and rath M: anti-atherogenic effects of a mixture of ascorbic acid, lysine, proline, arginine, cysteine, and green tea phenolics in human aortic smooth muscle cells. J cardiovasc Pharmacol 49: 140-145, 2007.
31. ivanov V, ivanova S, Kalinovsky T, niedzwiecki a and rath M: Plant-derived micronutrients suppress monocyte adhesion to cultured human aortic endothelial cell layer by modulating its extracellular matrix composition. J cardiovasc Pharmacol 52: 55-65, 2008.
32. rath M: Solution to the puzzle of human cardiovascular disease: its primary cause is ascorbate deficiency, leading to the deposition of lipoprotein(a) and fibrinogen/fibrin in the vascular wall. J ortho Med 6: 125-134, 1991.
33. Walmsley AR, Batten MR, lad u and Bulleid NJ: intracelllular retention of procollagen within the endoplasmic reticulum is mediated by prolyl 4-hydroxylase. J Biol chem 274: 14884-14892, 1999.
34. nakata y and Maeda n: Vulnerable atherosclerotic plaque morphology in apolipoprotein E-deficient mice unable to make ascorbic acid. circulation 105: 1485-1490, 2002.